Participants 460 490 4
subjects > or =50 years of age
Participants 492 594 5
Subjects with a negative history for HZ were randomized 1:1 to receive one dose of either formulation.
Participants 595 668 3
Enrollment was stratified 1:2 by age (50 to 59 years and > or =60 years).
